Literature DB >> 26764334

Fibroblast Growth Factor 21 (Fgf21) Gene Expression Is Elevated in the Liver of Mice Fed a High-Carbohydrate Liquid Diet and Attenuated by a Lipid Emulsion but Is Not Upregulated in the Liver of Mice Fed a High-Fat Obesogenic Diet.

Lei Hao1, Kuan-Hsun Huang1, Kyoko Ito1, Sudathip Sae-Tan2, Joshua D Lambert2, A Catharine Ross3.   

Abstract

BACKGROUND: Fibroblast growth factor 21 (FGF21) is a regulator of carbohydrate and lipid metabolism; however, the regulation of Fgf21 gene expression by diet remains incompletely understood.
OBJECTIVE: We investigated the effect of a high-carbohydrate (HC) liquid diet, with and without supplementation with a lipid emulsion (LE), and of a high-fat diet (HFD) compared with a low-fat diet (LFD) on the regulation of Fgf21 gene expression in the liver of intact mice.
METHODS: C57BL/6 male mice were fed standard feed pellets (SFPs), a purified HC liquid diet (adequate in calories and protein), or an HC liquid diet containing an LE at either 4% or 13.5% of energy for 5 wk (Expt. 1) or 1 wk (Expt. 2). In Expt. 3, mice were fed a purified LFD (∼10% fat) or HFD (∼60% fat) or were fed an HFD and given access to a running wheel for voluntary exercise for 16 wk.
RESULTS: Fgf21 mRNA in liver and FGF21 protein in plasma were increased by 3.5- to 7-fold in HC mice compared with SFP mice (P < 0.001), whereas the LE dose-dependently attenuated the induction of Fgf21 expression (P < 0.05). After 16 wk, hepatic Fgf21 mRNA did not differ between LFD and HFD mice but was dramatically reduced in the HFD+exercise group to <20% of the level in the HFD group (P < 0.0001).
CONCLUSIONS: In mice, hepatic Fgf21 expression was upregulated by 1 and 5 wk of feeding a lipogenic HC diet but not by 16 wk of feeding an obesogenic HFD, whereas the addition of fat as an LE to the HC formula significantly reduced Fgf21 gene expression and the plasma FGF21 protein concentration. Our results support a strong and reversible response of hepatic Fgf21 expression to shifts in dietary glucose intake.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  exercise; fibroblast growth factor; high-carbohydrate diet; high-fat diet; steatosis

Mesh:

Substances:

Year:  2016        PMID: 26764334      PMCID: PMC4725428          DOI: 10.3945/jn.115.216572

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  24 in total

Review 1.  Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.

Authors:  Pedro Iglesias; Rafael Selgas; Sara Romero; Juan J Díez
Journal:  Eur J Endocrinol       Date:  2012-06-27       Impact factor: 6.664

2.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

Authors:  Klementina Fon Tacer; Angie L Bookout; Xunshan Ding; Hiroshi Kurosu; George B John; Lei Wang; Regina Goetz; Moosa Mohammadi; Makoto Kuro-o; David J Mangelsdorf; Steven A Kliewer
Journal:  Mol Endocrinol       Date:  2010-07-28

3.  The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

Authors:  Cecilia Gälman; Tomas Lundåsen; Alexei Kharitonenkov; Holly A Bina; Mats Eriksson; Ingiäld Hafström; Maria Dahlin; Per Amark; Bo Angelin; Mats Rudling
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

4.  Fibroblast growth factor 21 corrects obesity in mice.

Authors:  Tamer Coskun; Holly A Bina; Michael A Schneider; James D Dunbar; Charlie C Hu; Yanyun Chen; David E Moller; Alexei Kharitonenkov
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

Review 5.  Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases.

Authors:  Alexei Kharitonenkov; Armen B Shanafelt
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

6.  Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.

Authors:  Michael K Badman; Anja Koester; Jeffrey S Flier; Alexei Kharitonenkov; Eleftheria Maratos-Flier
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

7.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

Authors:  Michael K Badman; Pavlos Pissios; Adam R Kennedy; George Koukos; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

8.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.

Authors:  Takeshi Inagaki; Paul Dutchak; Guixiang Zhao; Xunshan Ding; Laurent Gautron; Vinay Parameswara; Yong Li; Regina Goetz; Moosa Mohammadi; Victoria Esser; Joel K Elmquist; Robert D Gerard; Shawn C Burgess; Robert E Hammer; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

9.  Exercise increases serum fibroblast growth factor 21 (FGF21) levels.

Authors:  Daniel Cuevas-Ramos; Paloma Almeda-Valdés; Clara Elena Meza-Arana; Griselda Brito-Córdova; Francisco J Gómez-Pérez; Roopa Mehta; Jorge Oseguera-Moguel; Carlos A Aguilar-Salinas
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.

Authors:  Jing Xu; David J Lloyd; Clarence Hale; Shanaka Stanislaus; Michelle Chen; Glenn Sivits; Steven Vonderfecht; Randy Hecht; Yue-Sheng Li; Richard A Lindberg; Jin-Long Chen; Dae Young Jung; Zhiyou Zhang; Hwi-Jin Ko; Jason K Kim; Murielle M Véniant
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

View more
  4 in total

Review 1.  Sobriety and Satiety: Is NAD+ the Answer?

Authors:  Nady Braidy; Maria D Villalva; Sam van Eeden
Journal:  Antioxidants (Basel)       Date:  2020-05-14

Review 2.  Fibroblast Growth Factor 21 Facilitates the Homeostatic Control of Feeding Behavior.

Authors:  Chih-Ting Wu; Aki T Chaffin; Karen K Ryan
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.964

3.  Altered macronutrient composition and genetics influence the complex transcriptional network associated with adiposity in the Collaborative Cross.

Authors:  Phoebe Yam; Melissa VerHague; Jody Albright; Erik Gertz; Fernando Pardo-Manuel de Villena; Brian J Bennett
Journal:  Genes Nutr       Date:  2022-08-10       Impact factor: 4.423

Review 4.  Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges.

Authors:  Úrsula Martínez-Garza; Daniel Torres-Oteros; Alex Yarritu-Gallego; Pedro F Marrero; Diego Haro; Joana Relat
Journal:  Int J Mol Sci       Date:  2019-09-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.